Ohio Public Employees Retirement System (OPERS)
ZVRA icon

Ohio Public Employees Retirement System (OPERS)’s Zevra Therapeutics ZVRA Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,402
Closed -$90.2K – 2352
2024
Q2 		$90.2K Buy
18,402
+12,386
+206% +$58.7K ﹤0.01% 1443
2024
Q1 		$34.9K Buy
6,016
+679
+13% +$4.17K ﹤0.01% 1668
2023
Q4 		$35K Buy
5,337
+1,837
+52% +$8.59K ﹤0.01% 1672
2023
Q3 		$17K Buy
+3,500
New +$17.5K ﹤0.01% 1830

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s ZVRA Position: Q3 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Zevra Therapeutics (ZVRA) in Q3 2024, closing a stake of 18,402 shares — an estimated $90.2K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ZVRA in Q3 2023 and held it in 4 quarters. The position peaked at $90.2K in Q2 2024. 108 funds tracked by Wall St. Rank hold ZVRA as of Q3 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Zevra Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 18,402 Zevra Therapeutics shares in Q3 2024, an estimated $90.2K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Zevra Therapeutics in Q3 2023 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Zevra Therapeutics position peaked at $90.2K in Q2 2024.
  • 108 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2024, filed 15 Nov 2024.